Clinical Trials
3 trialsNCT01490632 2019-09-27
A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis
Eli Lilly and Company
Phase 2 Completed
NCT01107457 2019-09-24
A Study in Participants With Moderate to Severe Psoriasis
Eli Lilly and Company
Phase 2 Completed
NCT02908347 2019-01-23
Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients
MetrioPharm AG
Phase 2 Completed